Primary Site >> Colorectal Cancer
Gene >> DNER
|
|
|
|---|---|---|
|
Ref: CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. PMID: 26752646 Ref: BET bromodomain is a novel regulator of TAZ and its activity. PMID: 27717711 |
Ref: The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer. PMID: 27678457 Ref: Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway. PMID: 28576751 |
Ref: Anticancer Applications of Nanostructured Silica-Based Materials Functionalized with Titanocene Derivatives: Induction of Cell Death Mechanism through TNFR1 Modulation. PMID: 29385103 Ref: Co-inhibition of BET proteins and NF-kappaB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions. PMID: 29472532 Ref: ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone. PMID: 30098223 Ref: PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma. PMID: 30172011 |